Roka Bioscience (ROKA) Reports Q1 Loss of $1.53

Roka Bioscience (NASDAQ: ROKA) reported Q1 EPS of ($1.53), versus ($4.66) reported last year. Revenue for the quarter came in at $2 million, versus $1.6 million reported last year.

As of March 31, 2017, the Company had cash and cash equivalents and marketable securities of $16.2 million compared with $24.8 million at December 31, 2016.

For earnings history and earnings-related data on Roka Bioscience (ROKA) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
• S&P 500 may pull back before midterms, but Citi says buy the dip